InvestSMART

Pro Medicus Limited (ASX:PME)

ALERT: Price-sensitive ASX Announcement for PME
Current share price for PME : $198.980 19.99 (11.17%)+
Release
25 Jun 2026 9:07AM
Price at Release
$178.990
Full Release
download
Summary
Pro Medicus Limited, an Australian health imaging company, announced on 25 June 2026 that it has signed a binding Heads of Agreement with Echo IQ Ltd for a finance facility and reseller agreement. The partnership aims to support the development and commercialization of Echo IQ's AI solutions for aortic stenosis and heart failure. The agreement stipulates that definitive legal agreements are to be negotiated within 20 business days, or the deal may be terminated. Pro Medicus plans to integrate Echo IQ's technology with its Visage 7 Cardiology suite, aligning with its strategy of offering a curated mix of AI algorithms.
Key Points
  • Pro Medicus Limited signs a binding Heads of Agreement with Echo IQ Ltd.
  • The agreement includes a finance facility and reseller agreement.
  • Purpose is to develop and commercialize AI solutions for heart conditions.
  • Definitive agreements to be finalized in 20 business days.
  • Pro Medicus to offer Echo IQ technology to Visage 7 Cardiology customers.
  • Partnership aligns with Pro Medicus' AI strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.